基于siRNA的lncRNAs的淘汰:一种针对瘤进展的新方式
Abdulrahman Qais Khaleel1, Saade Abdalkareem Jasim2, Soumya V Menon3
1Department of Medical Instruments Engineering, Al-Maarif University College, Al Anbar 31001, Iraq.
Pathology, research and practice
|December 10, 2024
概括
小干扰RNA (siRNA) 通过向长非编码RNA (lncRNAs) 来显示癌症治疗的前景. 需要进一步的研究来克服个性化医疗的交付和有效性的挑战.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 在RNA治疗方面,RNA疗法.
背景情况:
- 长非编码RNAs (lncRNAs) 在癌症的发展和进展中发挥着不同的作用.
- 了解lncRNA结构和生物发生对于开发向疗法至关重要.
研究的目的:
- 评估小干扰RNA (siRNA) 作为向癌症中lncRNAs的治疗策略.
- 通过siRNA分析lncRNA抑制对癌症相关信号通路的影响.
主要方法:
- 癌症中的lncRNA结构,生物发生和功能的审查.
- 分析siRNA介导的lncRNA抑制及其对癌症信号传递的影响.
- 评估目前的临床试验和siRNA在瘤学中的应用.
主要成果:
- siRNA 显示出抑制促进癌症的 lncRNAs 的潜力.
- 通过siRNA抑制lncRNAs对关键的癌症信号通路产生影响.
- 目前正在进行的临床试验强调了基于siRNA的癌症干预措施的可行性.
结论:
- 基于siRNA的lncRNA的向为个性化癌症治疗和精准医学提供了一个有前途的途径.
- 关键的挑战包括优化siRNA传递,最大限度地减少非目标效应,提高临床应用的稳定性.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


